In practice, thrombophilia is often the reason why pregnancy does not occur or is terminated. Thrombophilia is a tendency to increased blood clotting. As a result, the patient is at increased risk of blood clots. Increased blood clotting can be caused by mutations in certain genes. The presence of these mutations increases the risk of thrombosis, and carriers of these genes are more likely to have complications during pregnancy (miscarriage, termination of pregnancy, intrauterine growth retardation of the fetus).
Complications of thrombophilia, especially in pregnant women, can be prevented by medical therapy. It is prescribed by the attending physician, taking into account family medical history, blood tests and results of molecular testing.
Timely diagnosis of thrombophilia can significantly improve the chances of successful pregnancy and the birth of a healthy child.
Blood or saliva.
If you choose to do the blood draw at the clinic on site, a blood collection fee will apply.
Test can be taken at the iVF Riga Genetics Centre, Riga, Zaļā Street 1, 2nd floor.
Registration: +371 67111117 or you can purchase a saliva collection kit remotely at www.ivfriga-online.lv/en
Genetic tests are carried out for persons over 18 years of age. Exceptions apply only with a referral from a clinical geneticist.
LATAK accreditation